Clinical Trial

Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to evaluate the safety and efficacy of sodium hyaluronate 32 mg/ml in improving facial skin dryness and dullness. Subjects are randomized to the treatment group or to the control group. Only subjects in the treatment group are treated by intradermal injection.
Trial Details
NCT Number NCT06914583
Lead Sponsor IBSA Farmaceutici Italia Srl
Conditions Facial Dryness, Facial Dullness
Enrollment 500 participants
Start Date 2025-02-19
Primary Completion 2025-11 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-04-06